Early low-fat diet enriched with linolenic acid reduces liver endocannabinoid tone and improves late glycemic control after a high-fat diet challenge in mice

Diabetes

Volumn 65, Issue 7, 2016, Pages 1824-1837

  Demizieux, Laurent ^a   Piscitelli, Fabiana ^b   Troy Fioramonti, Stephanie ^a   Iannotti, Fabio Arturo ^b   Borrino, Simona ^b   Gresti, Joseph ^a   Muller, Tania ^a   Bellenger, Jerome ^a   Silvestri, Cristoforo ^b   Di Marzo, Vincenzo ^b   Degrace, Pascal ^a  

^a Institut Médical de Génétique et d Immunologie   (France)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; LARD; LINOLENIC ACID; LINSEED OIL; SAFFLOWER OIL; ENDOCANNABINOID; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; FAT INTAKE; GLYCEMIC CONTROL; LIPID DIET; LIPID METABOLISM; LIVER; LOW FAT DIET; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE LEVEL; WILD TYPE; ANIMAL; BODY WEIGHT; C57BL MOUSE; FATTY LIVER; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; OBESITY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALPHA-LINOLENIC ACID; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATE METABOLISM; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; ENDOCANNABINOIDS; FATTY LIVER; HOMEOSTASIS; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY;

EID: 84975810730     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1279     Document Type: Article

References (52)

1. Di Marzo V, Goparaju SK, Wang L, et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-825
2. Quarta C, Mazza R, Obici S, Pasquali R, Pagotto U. Energy balance regulation by endocannabinoids at central and peripheral levels. Trends Mol Med 2011;17:518-526
3. Williams CM, Kirkham TC. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1999;143:315-317
4. Mallat A, Lotersztajn S. Endocannabinoids and their role in fatty liver disease. Dig Dis 2010;28:261-266
5. Jeong WI, Osei-Hyiaman D, Park O, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 2008;7:227-235
6. Jourdan T, Demizieux L, Gresti J, et al. Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants. Hepatology 2012;55:790-799
7. Buggy Y, Cornelius V, Wilton L, Shakir SA. Risk of depressive episodes with rimonabant: a before and after modified prescription event monitoring study conducted in England. Drug Saf 2011;34:501-509
8. Di Marzo V, Després JP. CB1 antagonists for obesity-what lessons have we learned from rimonabant? Nat Rev Endocrinol 2009;5:633-638
9. Di Marzo V. Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol 2008;160:1-24
10. Li J, Li FR, Wei D, et al. Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice. Mol Endocrinol 2014;28:1316-1328
11. Alvheim AR, Torstensen BE, Lin YH, et al. Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. Lipids 2014;49:59-69
12. Alvheim AR, Torstensen BE, Lin YH, et al. Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice. Br J Nutr 2013;109:1508-1517
13. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A 2001;98:6402-6406
14. Alvheim AR, Malde MK, Osei-Hyiaman D, et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 2012;20:1984-1994
15. Sato A, Kawano H, Notsu T, et al. Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 2010;59:2495-2504
16. Batetta B, Griinari M, Carta G, et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 2009;139:1495-1501
17. Kalupahana NS, Claycombe K, Newman SJ, et al. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 2010;140:1915-1922
18. Hein GJ, Chicco A, Lombardo YB. Fish oil normalizes plasma glucose levels and improves liver carbohydrate metabolism in rats fed a sucrose-rich diet. Lipids 2012;47:141-150
19. Chanda D, Kim DK, Li T, et al. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes. J Biol Chem 2011;286:27971-27979
20. Furuya DT, Poletto AC, Freitas HS, Machado UF. Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes. J Mol Endocrinol 2012;49: 97-106
21. Zalewski BM, Patro B, Veldhorst M, et al. Nutrition of infants and young children (1-3 years) and its effect on later health: a systematic review of current recommendations (EarlyNutrition Project). Crit Rev Food Sci Nutr. 9 March 2015 [Epub ahead of print]
22. Glavas MM, Kirigiti MA, Xiao XQ, et al. Early overnutrition results in early-onset arcuate leptin resistance and increased sensitivity to high-fat diet. Endocrinology 2010;151:1598-1610
23. Liu Z, Lim CY, Su MY, et al. Neonatal overnutrition in mice exacerbates high-fat diet-induced metabolic perturbations. J Endocrinol 2013;219:131-143
24. Massiera F, Barbry P, Guesnet P, et al. A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res 2010; 51:2352-2361
25. Pouteau E, Aprikian O, Grenot C, et al. A low alpha-linolenic intake during early life increases adiposity in the adult guinea pig. Nutr Metab (Lond) 2010;7:8
26. Massiera F, Saint-Marc P, Seydoux J, et al. Arachidonic acid and prosta-cyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 2003;44:271-279
27. González-Périz A, Horrillo R, Ferré N, et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2009;23:1946-1957
28. Romanatto T, Fiamoncini J, Wang B, Curi R, Kang JX. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice. Biochim Biophys Acta 2014;1842:186-191
29. Bellenger J, Bellenger S, Bataille A, et al. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011;60:1090-1099
30. Folch J, Lees M, Sloane Stanley GH A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509
31. Christie WW A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J Lipid Res 1982;23:1072-1075
32. Niot I, Gresti J, Boichot J, et al. Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver. Lipids 1994;29:481-489
33. Bartelt A, Orlando P, Mele C, et al. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia 2011;54:2900-2910
34. Iannotti FA, Piscitelli F, Martella A, et al. Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. Prostaglandins Leukot Essent Fatty Acids 2013;89:127-135
35. Matias I, Petrosino S, Racioppi A, Capasso R, Izzo AA, Di Marzo V. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Mol Cell Endocrinol 2008;286(Suppl. 1):S66-S78
36. Di Marzo V, Griinari M, Carta G, et al. Dietary krill oil increases docosa-hexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 2010;20:231-235
37. Sealls W, Gonzalez M, Brosnan MJ, Black PN, DiRusso CC. Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis. Biochim Biophys Acta 2008;1781:406-414
38. Elks ML Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 1993;133:208-214
39. Delarue J, LeFoll C, Corporeau C, Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 2004;44:289-299
40. Rossi AS, Lombardo YB, Chicco AG. Lipogenic enzyme activities and glucose uptake in fat tissue of dyslipemic, insulin-resistant rats: effects of fish oil. Nutrition 2010;26:209-217
41. White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 2010;59:3066-3073
42. Liu J, Zhou L, Xiong K, et al. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 2012;142:1218-1228.e1
43. Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 2013;17:475-490
44. Troy-Fioramonti S, Demizieux L, Gresti J, Muller T, Vergès B, Degrace P. Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice. Diabetes 2015;64: 808-818
45. Liu J, Cinar R, Xiong K, et al. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. Proc Natl Acad Sci USA 2013;110:18832-18837
46. Sullivan EL, Grove KL. Metabolic imprinting in obesity. Forum Nutr 2010;63: 186-194
47. Starowicz KM, Cristino L, Matias I, et al. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 2008;16:553-565
48. Piscitelli F, Carta G, Bisogno T, et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab (Lond) 2011;8:51
49. Annuzzi G, Piscitelli F, Di Marino L, et al. Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Lipids Health Dis 2010;9:43
50. Matias I, Gonthier MP, Orlando P, et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006;91:3171-3180
51. D'Eon TM, Pierce KA, Roix JJ, Tyler A, Chen H, Teixeira SR. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 2008;57:1262-1268
52. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-1033